Release originally posted on Crain’s Chicago Business Chicago-based sepsis diagnosing biotech Prenosis announced two $20 million milestones this morning, Series A financing and a large government contract. Read full release >
Prenosis Secures $40M to Advance Precision Medicine Infrastructure for Critical Care
Release originally posted on hlth.com Prenosis has announced the completion of a $20M Series A financing round alongside a $20M federal contract from the Biomedical Advanced Research and Development Authority (BARDA), bringing total new funding to $40M. The...
Chicago biotech startup Prenosis raises $40M to advance AI sepsis diagnostic tool
Release originally posted on Chicago Business Journal A local medtech startup behind an AI sepsis diagnostic tool recognized by TIME magazine has landed $40 million in funding. Read full release >
Prenosis Secures $40M to Build the Precision Medicine Network for Critical Care
Release originally posted on HIT Consultant The Chicago-based health tech company Prenosis revealed a dual milestone: the closing of a $20M Series A financing round and the awarding of a $20M contract from the Biomedical Advanced Research and Development Authority...
High-Profile Start-Ups Inato And Prenosis Show AI ‘Best Practice’
Article originally published in Forbes on May 22, 2025 Prenosis featured in article by author Michael L. Millenson, covering innovations at the 2025 MedCity INVEST conference in Chicago. “Treating artificial intelligence as just one ingredient in a business...
Sepsis ImmunoScore® Featured in JAMA
In a recent article titled “FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine,” published in JAMA by three senior FDA officials, Prenosis’ Sepsis ImmunoScore® was highlighted as a pivotal example of an AI...
Prenosis CEO Bobby Reddy, Jr. Recognized Among Crain’s Chicago 40 Under 40
Bobby Reddy, Jr., Co-Founder and CEO of Prenosis, has been named one of Crain’s Chicago Business 40 Under 40 for his visionary work in precision diagnostics and AI innovation. Under Bobby’s leadership, Prenosis has developed the Sepsis ImmunoScore™, the first...
Bobby Reddy, Jr. Discusses the Transformative Impact of AI on Sepsis Care–NewsNation Now
Bobby Reddy, Jr., Co-founder and CEO of Prenosis, appeared live on NewsNation Now for an in-depth, one-on-one interview about the transformative role of artificial intelligence in sepsis care. Airing just days after the FDA authorized the Sepsis ImmunoScore™, the...
Roche to distribute Prenosis’ AI sepsis detection tool in US–MedTech Dive
MedTech Dive, a trusted source for news and analysis in the medical technology industry, reports on Roche’s partnership with Prenosis. The Sepsis ImmunoScore™, a groundbreaking AI-powered tool, is available on Roche’s Navify Algorithm Suite, marking a...
Roche picks up Prenosis’ newly cleared sepsis AI tool for distribution–Fierce Biotech
Fierce Biotech, a leading authority in biotech and healthcare reporting, highlights Prenosis’ partnership with Roche to distribute the FDA-authorized Sepsis ImmunoScore™, bringing advanced AI-driven sepsis diagnostics to hospitals nationwide: Following last week’s de...